All Stories

  1. Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
  2. Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
  3. No Evidence of a Causal Role of Antiepileptic Drug Treatment with Regard to the Development of Dementia
  4. From clinical trials of antiepileptic drugs to treatment
  5. No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk-An analysis of Finnish health register and German health insurance data
  6. Advocacy for children with epilepsy: Leveraging the WHA resolution. Advocacy Task Force, Commission of Pediatrics, International League Against Epilepsy
  7. A simple and rapid HPLC-UV method for the determination of retigabine in human plasma
  8. Midazolam vs diazepam in prolonged seizures in children: A pharmacoeconomic approach
  9. How long for epilepsy remission in the ILAE definition?
  10. Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy
  11. In Memoriam: Hanneke De Boer (1946-2015)
  12. From global campaign to global commitment: The World Health Assembly's Resolution on epilepsy
  13. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy
  14. Commentary: Why an International Epilepsy Day?
  15. Commentary: Epilepsy is a Global Problem
  16. Introduction to the Clinical Definition of Epilepsy by the ILAE President
  17. In Memoriam: Harry Meinardi (February 20, 1932-December 20, 2013)